Ann Surg Treat Res.  2025 Apr;108(4):256-269. 10.4174/astr.2025.108.4.256.

Sporopollenin-based material for prevention of postoperative adhesions: a murine study

Affiliations
  • 1Sporogenics Private Limited, Singapore
  • 2Department of Materials Science and Engineering, National University of Singapore, Singapore
  • 3Duke-NUS Medical School, Singapore
  • 4Food, Chemical and Biotechnology Cluster, Singapore Institute of Technology, Singapore
  • 5Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea
  • 6Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Korea

Abstract

Purpose
This study was performed to evaluate the antiadhesive effect and safety of a novel adhesion barrier device (ABD) in comparison to other commercially available anti-adhesion products.
Methods
A 4-arm, controlled, blinded, experimental, and murine model study design was used. Forty male Sprague Dawley rats were randomly allocated to Interceed, Seprafilm, ABD, and control groups (n = 10/group). Abdominal cavity trauma was induced in all rats. Interceed, Seprafilm, or the ABD were applied to the injury site of each rat according to their respective groups, the control group received no intervention.
Results
Twenty-one days after the operation, surgical adhesion severity and area scores were significantly reduced in the Interceed, Seprafilm, and ABD groups compared to the control group (P = 0.016, P < 0.001, P < 0.001, respectively), and in the ABD group compared to the Interceed group (P = 0.036). No significant difference was observed between the ABD and Seprafilm groups (P = 0.070). Additionally, in the ABD group, no remnants of the ABD were observed at the injury site, and no hematological abnormalities were present.
Conclusion
The ABD has the potential to improve postsurgical peritoneal adhesions compared to Interceed and has comparable effectiveness compared to Seprafilm. The ABD may be a valuable option to reduce surgical failure. Further studies in human subjects are warranted to determine the clinical application and safety of the ABD for commercialization.

Keyword

Biopolymers; Immunomodulation; Pollen; Sporopollenin; Tissue adhesions
Full Text Links
  • ASTR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr